What Is SSBCI and Why Does It Matter to Brokers?

Special Supplemental Benefits for the Chronically Ill — commonly called SSBCI (pronounced S-B-C-I by CMS or sometimes referred to as “Special Supplemental Benefits”) — are non-medical supplemental benefits that Medicare Advantage plans may offer to members with qualifying chronic conditions. Unlike standard supplemental benefits that must be offered uniformly to all enrollees, SSBCI can be targeted and offered only to those who qualify as “chronically ill” under CMS’s three-part statutory definition.

These benefits have become one of the most significant value-add offerings in the Medicare Advantage market. They include things like:

• Meal delivery and food assistance programs
• Structural home modifications (grab bars, ramps, stair lifts)
• Non-medical transportation
• Personal emergency response systems (PERS)
• Pest control
• Air quality equipment and indoor air filters
• Social needs benefits addressing food insecurity, loneliness, and housing

For brokers, SSBCI matters because many clients choose — or stay enrolled in — a Medicare Advantage plan specifically because of these benefits. They are often a core retention tool and a key differentiator during AEP conversations.

Since CMS introduced SSBCI authority in 2020, some plans have loosely applied eligibility standards — or relied on member self-attestation — to qualify large portions of their enrollment base for these benefits. The 2027 Final Rule closes that door permanently.

The Four Major SSBCI Changes for 2027

Published April 6, 2026, in the Federal Register (CMS-4208-F3), the CY 2027 Medicare Advantage and Part D Final Rule codifies four landmark changes to how SSBCI benefits are administered. These provisions take effect January 1, 2027, with the public posting requirement also triggered by the June 1, 2026 rule effective date.

The New “Chronically Ill” Standard: What Qualifies in 2027?

One of the most important — and widely misunderstood — aspects of the 2027 SSBCI changes is the codification of the three-part “chronically ill enrollee” definition. Under the new rule, a Medicare Advantage enrollee must meet all three of the following criteria to be eligible for SSBCI benefits:

Does a diabetes diagnosis automatically qualify someone for SSBCI?

No. This is a critical point for brokers to understand and communicate to clients. Under the 2027 Final Rule, CMS explicitly states that diagnoses like diabetes, COPD, end-stage renal disease, or chronic heart failure alone do not automatically establish chronically ill status. The plan must still assess and document the remaining two criteria — high hospitalization risk and need for intensive care coordination — through objective means.

What counts as objective evidence for SSBCI eligibility?

CMS identifies the following as acceptable objective processes:

• Health Risk Assessments (HRAs) — including member-reported information as input, but not as the sole determination
• Review of medical claims data and diagnosis history
• Clinical records and care coordination documentation
• Other similar objective clinical evaluation methods

What about social determinants of health?

Plans may still consider social determinants of health — food insecurity, housing instability, transportation barriers — when evaluating whether a specific SSBCI is reasonably expected to improve a chronically ill enrollee’s health. However, social needs alone cannot serve as the basis for determining SSBCI eligibility. The three-part clinical standard must be met first.

What Benefits Are Covered Under SSBCI?

SSBCI benefits are distinct from the standard supplemental benefits Medicare Advantage plans offer uniformly to all enrollees (like dental, vision, or hearing). SSBCI are specifically for chronically ill members and are non-medical in nature — they are designed to address the broader health-related needs of high-risk individuals. According to KFF’s analysis of the 2027 Final Rule, these benefits can include:

What is NOT allowed as SSBCI starting 2027?

The 2027 Final Rule also clarifies what cannot be offered as SSBCI. Cannabis products that are illegal under applicable state or federal law are specifically prohibited. CMS did narrow this rule to preserve access to certain hemp-derived food ingredients recognized as safe by the FDA (hulled hemp seed, hemp seed protein powder, and hemp seed oil) — but only when all other SSBCI requirements are met, including the clinical evidence bibliography requirement.

How the 2027 SSBCI Changes Affect Brokers and Their Clients

Clients may lose benefits they counted on

Some clients who have been receiving SSBCI benefits in 2025 and 2026 may not qualify under the stricter 2027 standards. Plans that previously used self-attestation — allowing members to self-certify eligibility — will now need to verify eligibility through clinical documentation. Members who cannot be verified under the three-part standard may lose access to benefits they value highly.

This is especially relevant given the broader Medicare Advantage environment. As we covered in our analysis of MA carrier exits for 2027, hundreds of thousands of MA enrollees are already facing involuntary plan changes. Add SSBCI benefit disruption, and the potential for AEP-season switching conversations grows considerably.

The public posting requirement creates a new comparison tool

Starting January 1, 2027, every MA plan offering SSBCI must publish its complete eligibility criteria — the clinical standards used to determine who qualifies and for which specific benefits — on a publicly accessible website. This is a significant transparency shift. It means:

• Clients can independently verify whether they might qualify before enrolling
• Brokers can compare plan-specific SSBCI criteria across carriers during AEP research
• Advocacy groups and regulators can audit whether plans are adhering to posted standards
• Plans must apply their posted criteria consistently — no post-enrollment adjustments

No temporary benefits creates plan administration challenges — and enrollment timing implications

Under the old framework, some plans would begin providing SSBCI during a deeming or grace period while completing the eligibility review. The 2027 rule eliminates this entirely. Eligibility must be confirmed before any benefit is administered. Plans must now complete their full clinical review process — ideally through proactive HRAs before the January 1 coverage start — before an enrollee can begin receiving benefits.

For brokers, this means clients who choose a plan specifically for SSBCI benefits may experience a delay in accessing those benefits if the plan has not yet completed its eligibility determination. Setting client expectations in advance — particularly for January 1 effective dates — is essential.

How to Talk to Clients About the 2027 SSBCI Changes

Most Medicare clients do not follow regulatory policy. They know they receive certain benefits from their plan, and they expect those benefits to continue. The 2027 SSBCI changes require brokers to proactively communicate what is changing and why — before it affects a client’s coverage experience.

Talking points for client conversations

AEP 2026 Strategy: Using SSBCI Knowledge as a Competitive Advantage

Brokers who understand the 2027 SSBCI changes have a genuine competitive advantage during AEP 2026 (October 15 – December 7, 2026). Here is how to translate this regulatory knowledge into client outcomes and agency growth:

1. Proactively review your current book for SSBCI-dependent enrollees

Reach out to clients with chronic conditions — diabetes, COPD, heart failure, ESRD — who are enrolled in plans that heavily marketed supplemental benefits. These clients may be at risk of benefit disruption if their plan tightens eligibility determination. A proactive call positions you as a trusted advisor and captures any switching conversation before October 15.

For the broader picture on MA switching dynamics heading into this AEP, see our in-depth analysis: Medicare Switching Intent Is at a Record High Before AEP 2026.

2. Use the public posting requirement as a research tool

Once plans post their SSBCI eligibility criteria publicly (required by January 1, 2027, with many plans updating in advance of AEP), brokers can compare the clinical thresholds across plans. A client with diabetes plus a hospitalization history may qualify under one plan’s criteria but not another’s. This research capability is new for 2027 and should be part of every broker’s AEP plan comparison workflow.

3. SSBCI clarity is a natural bridge to Medicare Supplement conversations

For clients frustrated with SSBCI uncertainty — or those who find out they no longer qualify for benefits they valued — this is a natural opening to discuss the predictability of Medicare Supplement (Medigap) coverage. Medigap does not offer SSBCI-style benefits, but it does provide consistent coverage without eligibility gates or annual re-verification requirements. As we detailed in our complete broker comparison guide, Medicare Advantage vs. Medicare Supplement for 2027, the right choice depends on each client’s health profile, risk tolerance, and what they value most in their coverage.

4. Keep your AHIP certification current — it is required for Medicare sales

Before any Medicare sales or marketing activity during AEP 2026, brokers must hold current AHIP certification. Affordable Care Agents has an exclusive discount link through OIM to complete your AHIP training:

How Affordable Care Agents Helps You Navigate SSBCI and 2027 Compliance

Regulatory changes like the 2027 SSBCI overhaul are exactly the kind of complexity that separates producing brokers from struggling ones. Brokers who partner with the right FMO have access to the education, carrier access, and support structure they need to stay compliant, serve clients well, and grow through regulatory transitions — not despite them.

Affordable Care Agents is a national FMO/IMO helping licensed insurance professionals across the United States with:

• Multi-carrier contracting for Medicare Advantage, Medicare Supplement, and Part D plans
• AHIP certification support and access through the exclusive OIM discount link
• Compliance education and regulatory updates — including annual rule changes like the 2027 SSBCI requirements
• AEP planning and broker preparation resources
• Back-office support, appointment tracking, and CRM integration
• Lead programs and marketing resources tailored for Medicare brokers
• Agency growth and downline recruiting support for agencies building their own teams

Frequently Asked Questions About SSBCI 2027 Changes